Thelansis: Market Research Reports

The Team

Thelansis is the brain-child of specialized experts with multiple years of experience in healthcare management consulting.
Our core team is comprised of esteemed professionals, including reputed physicians, business analysts, and biotechnologists.
Thelansis combines global expertise and insight, with a rich mix of scientific and business development backgrounds.
We are guided by a strong set of values, including a commitment to professional diversity.

The Target

Our team strives to provide organizations with exceptional market research that will inform strategic business decisions.
We partner with organizations to help support their vision, and maintain a reputation as a Valued Knowledge Partner.

Publications found: 321

Sort by:

Medulloblastoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Medulloblastoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 172 pages

Metastatic Hepatocellular Carcinoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Hepatocellular Carcinoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

December 2017 192 pages

Metastatic Hormone Refractory Prostate Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Hormone Refractory Prostate Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology ... Myers Squibb, Cellcentric Ltd., Pfizer, Astellas Pharma Inc, Astrazeneca, Prostate Cancer Uk, Pfizer, Dextech Medical Ab, Immunomedics, Inc., Suzhou Kintor ...

December 2017 173 pages

Metastatic Prostate Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Prostate Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... Myers Squibb, Cellcentric Ltd., Pfizer, Astellas Pharma Inc, Astrazeneca, Prostate Cancer Uk, Pfizer, Dextech Medical Ab, Immunomedics, Inc., Suzhou Kintor ...

December 2017 152 pages

Metastatic Renal Cell Carcinoma (Mrcc) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Renal Cell Carcinoma (mRCC) ' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

December 2017 164 pages

Moderate Psoriasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Moderate Psoriasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 148 pages

Myasthenia Gravis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Myasthenia Gravis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 203 pages

Mycosis Fungoides - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Mycosis Fungoides' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 209 pages

Myelofibrosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Myelofibrosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 200 pages

Myopia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Myopia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 156 pages

Nasopharyngeal Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nasopharyngeal Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 170 pages

Neuroblastoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Neuroblastoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 217 pages

Nicotine Addiction - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nicotine Addiction' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 186 pages

Nocturia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nocturia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 218 pages

Non-Small Cell Lung Cancer (Nsclc) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Non-Small Cell Lung Cancer (NSCLC)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ... specific treatment and disease management for the patients with Non-Small Cell Lung Cancer (NSCLC) in the US, Europe, Japan, and China. Future treatment paradigm ...

December 2017 172 pages

Nosocomial Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nosocomial Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 211 pages

Lung Net (L Net) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Neuroendocrine Tumor(NET)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

December 2017 216 pages

Hepatitis D - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Hepatitis D' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

September 2017 214 pages

Major Depressive Disorder (Mdd) - Market Outlook, Market Forecast And Competitve Landscape Report - 20185 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Major Depressive Disorder (MDD)' - Market Outlook, Market Forecast ... , Prevalence and mortality) and forecasted trend for 8 major markets (US, Germany, France, Italy, Spain, UK, ... Phase I, Phase II and Phase III including their major milestones, study result, interim result, safety & ...

September 2017 257 pages

Attention Deficit Hyperactivity Disorder (Adhd) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Attention Deficit Hyperactivity Disorder (ADHD)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 275 pages

Acute Respiratory Distress Syndrome (Ards) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Acute Respiratory Distress Syndrome (ARDS)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 199 pages

Human Papillomavirus (Hpv) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Human Papillomavirus (HPV)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

September 2017 216 pages

Pulmonary Arterial Hypertension (Pah) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Pulmonary Arterial Hypertension (PAH)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 157 pages

Parkinson'S Disease - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Parkinson's Disease' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease overview, classifications, stages ...

September 2017 243 pages

Uveitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Uveitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

September 2017 204 pages

Cutaneous T-Cell Lymphoma(Ctcl) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Cutaneous T-Cell Lymphoma(CTCL)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

September 2017 195 pages

Peripheral T-Cell Lymphoma (Ptcl) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Peripheral T-Cell Lymphoma (PTCL)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 164 pages

Cutaneous Squamous Cell Carcinoma (Cscc) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Cutaneous Squamous cell Carcinoma (CsCC)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 201 pages

Interstitial Cystitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Interstitial Cystitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 208 pages

H3N2 Infection - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'H3N2 Infection' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 147 pages

Helicobacter Pylori Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Helicobacter Pylori Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

September 2017 217 pages

Hemophilia B - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hemophilia B' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 158 pages

Hepatic Encephalopathy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hepatic Encephalopathy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 190 pages

Hepatitis A - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hepatitis A' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 199 pages

Herpes Labialis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Herpes Labialis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 158 pages

Hospital Acquired Methicillin-Resistant Staphylococcus Aureus Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hospital Acquired Methicillin' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 155 pages

Hot Flashes - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hot Flashes' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

September 2017 157 pages

House Dust Mite Allergy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'House Dust Mite Allergy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

September 2017 154 pages

Hyperkalemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hyperkalemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

September 2017 184 pages

Hyperparathyroidism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hyperparathyroidism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

September 2017 200 pages

Hyperphosphatemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hyperphosphatemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

September 2017 158 pages

Hypertriglyceridemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hypertriglyceridemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

September 2017 196 pages

Hyperuricemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hyperuricemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

September 2017 208 pages

Herpetic Keratitis (Hk) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Herpetic Keratitis(HK)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

September 2017 165 pages

Sarcopenia - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

Thelansis Knowledge Partners 'Sarcopenia' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of ... level profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

June 2017 181 pages

Erectile Dysfunction (Ed) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Erectile Dysfunction (ED)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

June 2017 196 pages

Esophageal Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Esophageal Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 208 pages

Vasculitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Esophageal Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

June 2017 163 pages

Varicose Veins - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Varicose Veins' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 215 pages

Febrile Neutropenia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Febrile Neutropenia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 148 pages